High materiality8/10
Ideaya Biosciences price target lowered to $63 from $65 at Truist
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist lowers Ideaya Biosciences target to $63 from $65. Current price is $39.87. Target remains above price, indicating upside of about 58%.
- Target vs price: $63 vs $39.87; upside ~58%.
- Analyst: Truist.
Key facts
- 01
Target: $63
- 02
Posted price: $39.87
- 03
Analyst firm: Truist Financial
- 04
Analyst: Gregory Renza
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.